Nanil Therapeutics Inc.
1 known investors
Find your way into Nanil Therapeutics Inc.
162 people in our graph share verified history with the Nanil Therapeutics Inc. team — schools, employers, funds. One of them is your warm intro.
Logan Hilleunlockedknows Bini Raj Sky · together at Harvard University (overlapped)
knows the team · via University of California, San Francisco
×5knows the team · via Harvard University
×5knows the team · via The University of Bonn
Nanil Therapeutics develops AI-native discovery platforms for CNS-targeting therapeutic modalities, focusing on RNA-based approaches for neurodegenerative diseases like tauopathies and Alzheimer's. The company integrates quantum computing, generative AI, and molecular modeling to design and optimize mRNA therapeutics and identify blood-brain barrier-penetrant biologics.
Founders & leadership
AG
Anuj GuruacharyainComputational Lead
BR
Bini Raj SkyinPharmacology LeadBini Raj Sky holds a PhD in Pharmacology from the University of Virginia and has held postdoctoral and research positions in neuropharmacology at Harvard University and the University of California, San Francisco. He serves as Scientific Director at Nanil Therapeutics, which develops AI-powered discovery platforms for CNS-targeting RNA-based therapeutics.
Investors · 1
Frequently asked questions
- What does Nanil Therapeutics Inc. do?
- Nanil Therapeutics develops AI-native discovery platforms for CNS-targeting therapeutic modalities, focusing on RNA-based approaches for neurodegenerative diseases like tauopathies and Alzheimer's. The company integrates quantum computing, generative AI, and molecular modeling to design and optimize mRNA therapeutics and identify blood-brain barrier-penetrant biologics.
- Who are Nanil Therapeutics Inc.'s investors?
- Nanil Therapeutics Inc.'s investors include CABHI Ventures.